Alert on fraudulent use of the ODDO BHF identity
We have noted a multiplication of fraud attempts in which the name ODDO BHF is likely to be used. This is particularly the case for Portuguese-language websites that usurp ODDO BHF SE identity to invite you to make a payment. We would like to inform you that these websites are not legitimate and have been created by fraudsters. We therefore urge you to be extremely vigilant.
If you have any doubts about the authenticity of any documents or solicitations, please do not hesitate to contact your usual contacts directly or to contact us at +33 1 44 51 85 00.
Corporate Finance
Topics
Contact
Documentation for download
Healthcare
The Healthcare team at ODDO BHF provides an expertise coverage of international sub-sectors and local players or industries in Pharma, Medtech, certain Services sectors – Biopharma, CDMO, Spec Pharma, Gx, APIs, CDMOs, CROs, IVD, CLIA Labs, certain Digital Health, Orthopedics and biomaterials and other medtech sectors.
Learn moreSenior Team
Laurent Buiatti
Managing DirectorJoséphine Hicter
DirectorManaging Director
Joined ODDO BHF in 2022
Started his career at Arthur Andersen Paris for 5 years
He spent 10 years at Rothschild & Cie Paris
He then co-managed the Transaction R team at Rothschild Paris from 2007 to 2021
He graduated from Centrale Paris and INSEAD
Director
Joined ODDO BHF in 2020
Worked 2 years at Oaks Field Partners and 1 year at Natixis
Studied at AgroParisTech
Technical Expertise
M&A
€25-500M deals
Sell-side mandates / Selective buy-side mandates
Cross-border transactions
Carve-out, transmission of family-owned businesses
Special situations
Broad relationship with Private Equity funds
Debt advisory
Banking facilities
Private Debt
Special situations
DCM
Bonds/EuroPP/Schuldschein
Convertible Bond
Public M&A / ECM
IPO
Block trades
Capital increases